Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B Dosing Schedule in Childhood Acute Leukemia With Invasive Fungal Disease
ChiCTR-IPR-17011449Phase 4Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amphotericin b in invasive mycoses and Acute Leukaemia (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: efficacy, adverse events and 1 more. Started Jan 2016; status: completed.
02
Drugs
amphotericin b
03
Conditions
invasive mycosesAcute Leukaemia
Beyond the preview
Go deeper on ChiCTR-IPR-17011449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011449.